Patents Assigned to CMTx Biotech Inc.
  • Publication number: 20230113011
    Abstract: A method of treating COVID-19 in a human in need thereof. The method comprises administering a tetracycline compound in an amount that is effective to treat COVID-19, but has substantially no antibacterial activity.
    Type: Application
    Filed: March 12, 2021
    Publication date: April 13, 2023
    Applicant: CMTx Biotech Inc.
    Inventors: Joseph Scaduto, James Keane